Kamila Clarová

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry(Current)

Czech Academy of Sciences

Kamila Clarová is an author at Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry specializing in antiviral therapy, innate immunity, and infectious diseases.

ORCID

Publications per year

2020–2024

Publications

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes

V. Janovec, Jan Hodek, Kamila Clarová et al. · Scientific Reports · 2020 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Mutation Maker, An Open Source Oligo Design Platform for Protein Engineering

Kaori Hiraga, Petr Mejzlík, Matej Marcisin et al. · ACS Synthetic Biology · 2021 · 12 citations · Full text

Engineering, Biomolecular Engineering, Biotechnology +15

Deciphering the allosteric regulation of mycobacterial inosine-5′-monophosphate dehydrogenase

Ondřej Bulvas, Zdeněk Knejzlı́k, Jakub Sýs et al. · Nature Communications · 2024 · 12 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

The mycobacterial <i>guaB1</i> gene encodes a guanosine 5′‐monophosphate reductase with a cystathionine‐β‐synthase domain

Zdeněk Knejzlı́k, Michal Doležal, Klára Herkommerová et al. · FEBS Journal · 2022 · 11 citations · Full text

Life Sciences, Microbiology, Molecular Biology +13

1–4 of 4